Table 5.
BCC localizations distributions among subgroups, n (%).
| Localization | Cancer history | Immunosuppressants | DM | CKD | Chronic infections |
|---|---|---|---|---|---|
| Nose | 14 (29.79%) | — | 15 (22.06%) | 1 (7.69%) | 5 (35.71%) |
| Forehead | 7 (14.89%) | 2 (12.5%) | 2 (2.94%) | 2 (15.38%) | — |
| Cheeks | 10 (21.28%) | 4 (25%) | 15 (22.06%) | 4 (30.77%) | 1 (7.14%) |
| Neck | — | 1 (6.25%) | 1 (1.47%) | — | 1 (7.14%) |
| Ears | 2 (4.26%) | 1 (6.25%) | 1 (1.47%) | — | — |
| Scalp | — | — | 7 (10.29%) | — | — |
| Trunk | 11 (23.40%) | 8 (50%) | 27 (39.71%) | 5 (38.46%) | 7 (50%) |
| Limbs | 3 (6.38%) | — | — | 1 (7.69%) | — |
CKD, chronic kidney disease; DM, diabetes mellitus. p-value = 0.008063, Fisher exact test with a simulated p-value.